Publications
Filtres: Autor és López, T [Clear All Filters]
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36. Abstract
CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Digestive diseases and sciences. 2008;53(5):1417-21. Abstract
Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704. Abstract
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of epidemiology and community health. 2007;61(7):641-9. Abstract
Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30. Abstract
Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41. Abstract
Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9. Abstract
